MUMBAI, India, June 16 -- Intellectual Property India has published a patent application (202611054062 A) filed by Khushboo Majumdar; Sushil Kumar; Anurag Sharma; Jatin Kishore Sharma; Sagar Varshney; and Dr. Akhlesh Kumari, Moradabad, Uttar Pradesh, on April 28, for 'synthesis and characterization of 2-(4-(phenyl) piperazin-1-yl)-n-(4-((2- oxoindolin-3-ylidene) amino) phenyl) acetamide.'
Inventor(s) include Khushboo Majumdar; Sushil Kumar; Anurag Sharma; Jatin Kishore Sharma; Sagar Varshney; and Dr. Akhlesh Kumari.
The application for the patent was published on June 5, under issue no. 23/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel heterocyclic compound, namely 2-(4-(phenyl) piperazin-1-yl)-N-(4-((2-oxoindolin-3-ylidene) amino) phenyl) acetamide, and a method for its synthesis and characterization. The compound is prepared through a multi-step process involving the reaction of isatin with 1,4-diaminobenzene in the presence of glacial acetic acid to form an intermediate, followed by chloroacetylation to obtain a chloroacetamide derivative. The resulting intermediate is further reacted with phenylpiperazine in the presence of a base in an appropriate solvent to yield the final product. The synthesized compound is isolated, purified, and characterized using analytical techniques including melting point determination, thin-layer chromatography (TLC), infrared (IR) spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. The compound demonstrates satisfactory yield and structural integrity, and may be useful for potential pharmaceutical and medicinal applications."
Disclaimer: Curated by HT Syndication.
